COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease.
Rodriguez Z, Shane AL, Verkerke H, Lough C, Zimmerman MG, Suthar M, Wrammert J, MacDonald H, Wolf M, Clarke S, Roback JD, Arthur CM, Stowell SR, Josephson CD.
Rodriguez Z, et al.
Blood Adv. 2020 Sep 22;4(18):4278-4281. doi: 10.1182/bloodadvances.2020002507.
Blood Adv. 2020.
PMID: 32915971
Free PMC article.